Management and Molecular Diagnosis of Persistent Müllerian Duct Syndrome in Chinese Patients

Hongjuan Tian,Dehua Wu,Wei Ru,Dingwen Wu,Chang Tao,Guangjie Chen,Jinna Yuan,Junfen Fu,Daxing Tang

DOI: https://doi.org/10.21203/rs.3.rs-443766/v1

2021-01-01

Abstract:Abstract Background: To report the management and molecular findings of patients with persistent Müllerian duct syndrome (PMDS).Materials and Methods: The hospital records of PMDS patients seen in our center between 2012 and 2020 were retrospectively reviewed. Exome sequencing and Sanger verification were performed for accurate diagnosis. We also reviewed reported clinical and molecular data on PMDS.Results: A total of 12 PMDS patients with a median age of 13 months and a median follow-up time of 25 months were included in the study. Preoperative diagnoses were obtained on the basis of ultrasound (7/12) and exome sequencing (1/12). Twelve different AMH variants in 9 patients (2 frameshift/nonsense, 1 deletion, 8 missense, 1 in-frame) and 6 different AMHR2 variants in 3 patients (5 missense, 1 splicing) were identified. Not all patients with AMH defects showed low serum AMH concentrations (2/9), but all patients with AMHR2 defects showed elevated AMH levels (3/3). During surgery, an abnormal vas deferens was observed in half of the patients. Patients with orchidopexy with uterine preservation presented complications including irreducible cryptorchidism (2/8) and Müllerian remnant cysts (3/8). Patients with subtotal hysterectomy had complications of injury to the vas deferens (1/3) and hemorrhage (1/3).Conclusions: This is the first report involving a large Chinese population. The present study not only expands the variation spectrum but also provides new insights into the management of the uterus.